aluates Reports

$ 0.0

Automative

Global Insulin Degludec Market Research Report 2025

Published Date: 2025-06-04

Report Code: QYRE-Auto-4Q16415

Global Insulin Degludec Market Research Report 2023

BUY CHAPTERS

Global Insulin Degludec Market Research Report 2025

Code: QYRE-Auto-4Q16415

Report

2025-06-04

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Jiangsu Wanbang Biopharmaceuticals

Zhuhai United Laboratories

Sunshine Lake Pharma

Chia Tai-Tianqing Pharmaceutical

Jilin Huisheng Biopharmaceutical

Insulin Degludec Market

The global market for Insulin Degludec was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Insulin degludec is a new generation of long-acting basal insulin analogues developed by Novo Nordisk. As of now, there are no biosimilars of insulin degludec on the market globally, and other companies are in the research and development and marketing application stages.

North American market for Insulin Degludec is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Insulin Degludec is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Insulin Degludec include Novo Nordisk, Jilin Huisheng Biopharmaceutical, Jiangsu Wanbang Biopharmaceuticals, Zhuhai United Laboratories, Sunshine Lake Pharma, Chia Tai Tianqing Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Insulin Degludec, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Degludec.

The Insulin Degludec market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Insulin Degludec market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Insulin Degludec manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Insulin Degludec Market Report

Report Metric	Details
Report Name	Insulin Degludec Market
Segment by Type	Insulin Degludec Injection Mixed Injection
Segment by Application	Type 1 Diabetes Type 2 Diabetes
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Novo Nordisk, Jilin Huisheng Biopharmaceutical, Jiangsu Wanbang Biopharmaceuticals, Zhuhai United Laboratories, Sunshine Lake Pharma, Chia Tai Tianqing Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Insulin Degludec manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Insulin Degludec in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Insulin Degludec Market report?

Ans: The main players in the Insulin Degludec Market are Novo Nordisk, Jilin Huisheng Biopharmaceutical, Jiangsu Wanbang Biopharmaceuticals, Zhuhai United Laboratories, Sunshine Lake Pharma, Chia Tai Tianqing Pharmaceutical

What are the Application segmentation covered in the Insulin Degludec Market report?

Ans: The Applications covered in the Insulin Degludec Market report are Type 1 Diabetes, Type 2 Diabetes

What are the Type segmentation covered in the Insulin Degludec Market report?

Ans: The Types covered in the Insulin Degludec Market report are Insulin Degludec Injection, Mixed Injection

1 Insulin Degludec Market Overview

1.1 Product Definition

1.2 Insulin Degludec by Type

1.2.1 Global Insulin Degludec Market Value Comparison by Type (2024 VS 2031)

1.2.2 Insulin Degludec Injection

1.2.3 Mixed Injection

1.3 Insulin Degludec by Application

1.3.1 Global Insulin Degludec Market Value by Application (2024 VS 2031)

1.3.2 Type 1 Diabetes

1.3.3 Type 2 Diabetes

1.4 Global Insulin Degludec Market Size Estimates and Forecasts

1.4.1 Global Insulin Degludec Revenue 2020-2031

1.4.2 Global Insulin Degludec Sales 2020-2031

1.4.3 Global Insulin Degludec Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Insulin Degludec Market Competition by Manufacturers

2.1 Global Insulin Degludec Sales Market Share by Manufacturers (2020-2025)

2.2 Global Insulin Degludec Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Insulin Degludec Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Insulin Degludec, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Insulin Degludec, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Insulin Degludec, Product Type & Application

2.7 Global Key Manufacturers of Insulin Degludec, Date of Enter into This Industry

2.8 Global Insulin Degludec Market Competitive Situation and Trends

2.8.1 Global Insulin Degludec Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Insulin Degludec Players Market Share by Revenue

2.8.3 Global Insulin Degludec Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Insulin Degludec Market Scenario by Region

3.1 Global Insulin Degludec Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Insulin Degludec Sales by Region: 2020-2031

3.2.1 Global Insulin Degludec Sales by Region: 2020-2025

3.2.2 Global Insulin Degludec Sales by Region: 2026-2031

3.3 Global Insulin Degludec Revenue by Region: 2020-2031

3.3.1 Global Insulin Degludec Revenue by Region: 2020-2025

3.3.2 Global Insulin Degludec Revenue by Region: 2026-2031

3.4 North America Insulin Degludec Market Facts & Figures by Country

3.4.1 North America Insulin Degludec Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Insulin Degludec Sales by Country (2020-2031)

3.4.3 North America Insulin Degludec Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Insulin Degludec Market Facts & Figures by Country

3.5.1 Europe Insulin Degludec Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Insulin Degludec Sales by Country (2020-2031)

3.5.3 Europe Insulin Degludec Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Insulin Degludec Market Facts & Figures by Region

3.6.1 Asia Pacific Insulin Degludec Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Insulin Degludec Sales by Region (2020-2031)

3.6.3 Asia Pacific Insulin Degludec Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Insulin Degludec Market Facts & Figures by Country

3.7.1 Latin America Insulin Degludec Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Insulin Degludec Sales by Country (2020-2031)

3.7.3 Latin America Insulin Degludec Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Insulin Degludec Market Facts & Figures by Country

3.8.1 Middle East and Africa Insulin Degludec Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Insulin Degludec Sales by Country (2020-2031)

3.8.3 Middle East and Africa Insulin Degludec Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Insulin Degludec Sales by Type (2020-2031)

4.1.1 Global Insulin Degludec Sales by Type (2020-2025)

4.1.2 Global Insulin Degludec Sales by Type (2026-2031)

4.1.3 Global Insulin Degludec Sales Market Share by Type (2020-2031)

4.2 Global Insulin Degludec Revenue by Type (2020-2031)

4.2.1 Global Insulin Degludec Revenue by Type (2020-2025)

4.2.2 Global Insulin Degludec Revenue by Type (2026-2031)

4.2.3 Global Insulin Degludec Revenue Market Share by Type (2020-2031)

4.3 Global Insulin Degludec Price by Type (2020-2031)

5 Segment by Application

5.1 Global Insulin Degludec Sales by Application (2020-2031)

5.1.1 Global Insulin Degludec Sales by Application (2020-2025)

5.1.2 Global Insulin Degludec Sales by Application (2026-2031)

5.1.3 Global Insulin Degludec Sales Market Share by Application (2020-2031)

5.2 Global Insulin Degludec Revenue by Application (2020-2031)

5.2.1 Global Insulin Degludec Revenue by Application (2020-2025)

5.2.2 Global Insulin Degludec Revenue by Application (2026-2031)

5.2.3 Global Insulin Degludec Revenue Market Share by Application (2020-2031)

5.3 Global Insulin Degludec Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Novo Nordisk

6.1.1 Novo Nordisk Company Information

6.1.2 Novo Nordisk Description and Business Overview

6.1.3 Novo Nordisk Insulin Degludec Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Novo Nordisk Insulin Degludec Product Portfolio

6.1.5 Novo Nordisk Recent Developments/Updates

6.2 Jilin Huisheng Biopharmaceutical

6.2.1 Jilin Huisheng Biopharmaceutical Company Information

6.2.2 Jilin Huisheng Biopharmaceutical Description and Business Overview

6.2.3 Jilin Huisheng Biopharmaceutical Insulin Degludec Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Jilin Huisheng Biopharmaceutical Insulin Degludec Product Portfolio

6.2.5 Jilin Huisheng Biopharmaceutical Recent Developments/Updates

6.3 Jiangsu Wanbang Biopharmaceuticals

6.3.1 Jiangsu Wanbang Biopharmaceuticals Company Information

6.3.2 Jiangsu Wanbang Biopharmaceuticals Description and Business Overview

6.3.3 Jiangsu Wanbang Biopharmaceuticals Insulin Degludec Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Jiangsu Wanbang Biopharmaceuticals Insulin Degludec Product Portfolio

6.3.5 Jiangsu Wanbang Biopharmaceuticals Recent Developments/Updates

6.4 Zhuhai United Laboratories

6.4.1 Zhuhai United Laboratories Company Information

6.4.2 Zhuhai United Laboratories Description and Business Overview

6.4.3 Zhuhai United Laboratories Insulin Degludec Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Zhuhai United Laboratories Insulin Degludec Product Portfolio

6.4.5 Zhuhai United Laboratories Recent Developments/Updates

6.5 Sunshine Lake Pharma

6.5.1 Sunshine Lake Pharma Company Information

6.5.2 Sunshine Lake Pharma Description and Business Overview

6.5.3 Sunshine Lake Pharma Insulin Degludec Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Sunshine Lake Pharma Insulin Degludec Product Portfolio

6.5.5 Sunshine Lake Pharma Recent Developments/Updates

6.6 Chia Tai Tianqing Pharmaceutical

6.6.1 Chia Tai Tianqing Pharmaceutical Company Information

6.6.2 Chia Tai Tianqing Pharmaceutical Description and Business Overview

6.6.3 Chia Tai Tianqing Pharmaceutical Insulin Degludec Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Chia Tai Tianqing Pharmaceutical Insulin Degludec Product Portfolio

6.6.5 Chia Tai Tianqing Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Insulin Degludec Industry Chain Analysis

7.2 Insulin Degludec Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Insulin Degludec Production Mode & Process Analysis

7.4 Insulin Degludec Sales and Marketing

7.4.1 Insulin Degludec Sales Channels

7.4.2 Insulin Degludec Distributors

7.5 Insulin Degludec Customer Analysis

8 Insulin Degludec Market Dynamics

8.1 Insulin Degludec Industry Trends

8.2 Insulin Degludec Market Drivers

8.3 Insulin Degludec Market Challenges

8.4 Insulin Degludec Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Jiangsu Wanbang Biopharmaceuticals

Zhuhai United Laboratories

Sunshine Lake Pharma

Chia Tai-Tianqing Pharmaceutical

Jilin Huisheng Biopharmaceutical

List of Tables

Table 1. Global Insulin Degludec Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Insulin Degludec Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Insulin Degludec Market Competitive Situation by Manufacturers in 2024

Table 4. Global Insulin Degludec Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Insulin Degludec Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Insulin Degludec Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Insulin Degludec Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Insulin Degludec Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Insulin Degludec, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Insulin Degludec, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Insulin Degludec, Product Type & Application

Table 12. Global Key Manufacturers of Insulin Degludec, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Insulin Degludec by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Degludec as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Insulin Degludec Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Insulin Degludec Sales by Region (2020-2025) & (K Units)

Table 18. Global Insulin Degludec Sales Market Share by Region (2020-2025)

Table 19. Global Insulin Degludec Sales by Region (2026-2031) & (K Units)

Table 20. Global Insulin Degludec Sales Market Share by Region (2026-2031)

Table 21. Global Insulin Degludec Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Insulin Degludec Revenue Market Share by Region (2020-2025)

Table 23. Global Insulin Degludec Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Insulin Degludec Revenue Market Share by Region (2026-2031)

Table 25. North America Insulin Degludec Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Insulin Degludec Sales by Country (2020-2025) & (K Units)

Table 27. North America Insulin Degludec Sales by Country (2026-2031) & (K Units)

Table 28. North America Insulin Degludec Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Insulin Degludec Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Insulin Degludec Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Insulin Degludec Sales by Country (2020-2025) & (K Units)

Table 32. Europe Insulin Degludec Sales by Country (2026-2031) & (K Units)

Table 33. Europe Insulin Degludec Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Insulin Degludec Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Insulin Degludec Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Insulin Degludec Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Insulin Degludec Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Insulin Degludec Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Insulin Degludec Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Insulin Degludec Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Insulin Degludec Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Insulin Degludec Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Insulin Degludec Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Insulin Degludec Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Insulin Degludec Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Insulin Degludec Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Insulin Degludec Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Insulin Degludec Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Insulin Degludec Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Insulin Degludec Sales (K Units) by Type (2020-2025)

Table 51. Global Insulin Degludec Sales (K Units) by Type (2026-2031)

Table 52. Global Insulin Degludec Sales Market Share by Type (2020-2025)

Table 53. Global Insulin Degludec Sales Market Share by Type (2026-2031)

Table 54. Global Insulin Degludec Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Insulin Degludec Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Insulin Degludec Revenue Market Share by Type (2020-2025)

Table 57. Global Insulin Degludec Revenue Market Share by Type (2026-2031)

Table 58. Global Insulin Degludec Price (US$/Unit) by Type (2020-2025)

Table 59. Global Insulin Degludec Price (US$/Unit) by Type (2026-2031)

Table 60. Global Insulin Degludec Sales (K Units) by Application (2020-2025)

Table 61. Global Insulin Degludec Sales (K Units) by Application (2026-2031)

Table 62. Global Insulin Degludec Sales Market Share by Application (2020-2025)

Table 63. Global Insulin Degludec Sales Market Share by Application (2026-2031)

Table 64. Global Insulin Degludec Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Insulin Degludec Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Insulin Degludec Revenue Market Share by Application (2020-2025)

Table 67. Global Insulin Degludec Revenue Market Share by Application (2026-2031)

Table 68. Global Insulin Degludec Price (US$/Unit) by Application (2020-2025)

Table 69. Global Insulin Degludec Price (US$/Unit) by Application (2026-2031)

Table 70. Novo Nordisk Company Information

Table 71. Novo Nordisk Description and Business Overview

Table 72. Novo Nordisk Insulin Degludec Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Novo Nordisk Insulin Degludec Product

Table 74. Novo Nordisk Recent Developments/Updates

Table 75. Jilin Huisheng Biopharmaceutical Company Information

Table 76. Jilin Huisheng Biopharmaceutical Description and Business Overview

Table 77. Jilin Huisheng Biopharmaceutical Insulin Degludec Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Jilin Huisheng Biopharmaceutical Insulin Degludec Product

Table 79. Jilin Huisheng Biopharmaceutical Recent Developments/Updates

Table 80. Jiangsu Wanbang Biopharmaceuticals Company Information

Table 81. Jiangsu Wanbang Biopharmaceuticals Description and Business Overview

Table 82. Jiangsu Wanbang Biopharmaceuticals Insulin Degludec Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Jiangsu Wanbang Biopharmaceuticals Insulin Degludec Product

Table 84. Jiangsu Wanbang Biopharmaceuticals Recent Developments/Updates

Table 85. Zhuhai United Laboratories Company Information

Table 86. Zhuhai United Laboratories Description and Business Overview

Table 87. Zhuhai United Laboratories Insulin Degludec Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Zhuhai United Laboratories Insulin Degludec Product

Table 89. Zhuhai United Laboratories Recent Developments/Updates

Table 90. Sunshine Lake Pharma Company Information

Table 91. Sunshine Lake Pharma Description and Business Overview

Table 92. Sunshine Lake Pharma Insulin Degludec Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Sunshine Lake Pharma Insulin Degludec Product

Table 94. Sunshine Lake Pharma Recent Developments/Updates

Table 95. Chia Tai Tianqing Pharmaceutical Company Information

Table 96. Chia Tai Tianqing Pharmaceutical Description and Business Overview

Table 97. Chia Tai Tianqing Pharmaceutical Insulin Degludec Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Chia Tai Tianqing Pharmaceutical Insulin Degludec Product

Table 99. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates

Table 100. Key Raw Materials Lists

Table 101. Raw Materials Key Suppliers Lists

Table 102. Insulin Degludec Distributors List

Table 103. Insulin Degludec Customers List

Table 104. Insulin Degludec Market Trends

Table 105. Insulin Degludec Market Drivers

Table 106. Insulin Degludec Market Challenges

Table 107. Insulin Degludec Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Product Picture of Insulin Degludec

Figure 2. Global Insulin Degludec Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Insulin Degludec Market Share by Type: 2024 & 2031

Figure 4. Insulin Degludec Injection Product Picture

Figure 5. Mixed Injection Product Picture

Figure 6. Global Insulin Degludec Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Insulin Degludec Market Share by Application: 2024 & 2031

Figure 8. Type 1 Diabetes

Figure 9. Type 2 Diabetes

Figure 10. Global Insulin Degludec Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Insulin Degludec Market Size (2020-2031) & (US$ Million)

Figure 12. Global Insulin Degludec Sales (2020-2031) & (K Units)

Figure 13. Global Insulin Degludec Average Price (US$/Unit) & (2020-2031)

Figure 14. Insulin Degludec Report Years Considered

Figure 15. Insulin Degludec Sales Share by Manufacturers in 2024

Figure 16. Global Insulin Degludec Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest Insulin Degludec Players: Market Share by Revenue in Insulin Degludec in 2024

Figure 18. Insulin Degludec Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global Insulin Degludec Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America Insulin Degludec Sales Market Share by Country (2020-2031)

Figure 21. North America Insulin Degludec Revenue Market Share by Country (2020-2031)

Figure 22. United States Insulin Degludec Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada Insulin Degludec Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe Insulin Degludec Sales Market Share by Country (2020-2031)

Figure 25. Europe Insulin Degludec Revenue Market Share by Country (2020-2031)

Figure 26. Germany Insulin Degludec Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France Insulin Degludec Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. Insulin Degludec Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy Insulin Degludec Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia Insulin Degludec Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Insulin Degludec Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific Insulin Degludec Revenue Market Share by Region (2020-2031)

Figure 33. China Insulin Degludec Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan Insulin Degludec Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea Insulin Degludec Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India Insulin Degludec Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia Insulin Degludec Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. China Taiwan Insulin Degludec Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Insulin Degludec Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Latin America Insulin Degludec Sales Market Share by Country (2020-2031)

Figure 41. Latin America Insulin Degludec Revenue Market Share by Country (2020-2031)

Figure 42. Mexico Insulin Degludec Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Brazil Insulin Degludec Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Argentina Insulin Degludec Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Middle East and Africa Insulin Degludec Sales Market Share by Country (2020-2031)

Figure 46. Middle East and Africa Insulin Degludec Revenue Market Share by Country (2020-2031)

Figure 47. Turkey Insulin Degludec Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Insulin Degludec Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. UAE Insulin Degludec Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Global Sales Market Share of Insulin Degludec by Type (2020-2031)

Figure 51. Global Revenue Market Share of Insulin Degludec by Type (2020-2031)

Figure 52. Global Insulin Degludec Price (US$/Unit) by Type (2020-2031)

Figure 53. Global Sales Market Share of Insulin Degludec by Application (2020-2031)

Figure 54. Global Revenue Market Share of Insulin Degludec by Application (2020-2031)

Figure 55. Global Insulin Degludec Price (US$/Unit) by Application (2020-2031)

Figure 56. Insulin Degludec Value Chain

Figure 57. Channels of Distribution (Direct Vs Distribution)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions